JK - TRADING
In vitro diagnostics and laboratory product distribution for healthcare facilities in Slovakia and the Czech Republic
Highlights
- ProfitableFY2025 net profit €29k · RÚZ
- New on EvolcAdded 2026-11-08
About JK - TRADING
JK-TRADING distributes in vitro diagnostics, laboratory equipment, vaccines, infection diagnostics, and related medical products. It also sources products outside its catalogue and transports temperature-controlled goods with a monitored cold chain.
The company supplies healthcare facilities and provides consignment stock, transport, and product information through sales representatives. It distributes products from BioSystems, MESA Labs, BAG Diagnostic, ulti med, and Zeakon.
Founded in 1993 according to registry facts, JK-TRADING is headquartered in Stupava and serves the Czech and Slovak markets. It presents branches in Karlovy Vary, Prague, Brno, and Bratislava.
Product: Distribution and cold-chain transport of in vitro diagnostics, laboratory equipment, vaccines, and other medical products.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €899k | €887k | €803k | €783k | €703k |
| Growth | +1% | +10% | +3% | +11% | — |
| EBITDA | €37k | €46k | €16k | €6k | −€6k |
| Operating profit | €37k | €46k | €16k | €6k | −€6k |
| Net profit | €29k | €36k | €13k | €5k | −€6k |
| Net margin | 3.2% | 4.1% | 1.7% | 0.6% | −0.8% |
| Personnel costs | €99k | €93k | €93k | €96k | €97k |
| Total assets | €371k | €345k | €428k | €439k | €359k |
| Cash | €187k | €176k | €141k | €153k | €19k |
| Liabilities | €95k | €97k | €116k | €140k | €64k |
| Equity | €277k | €248k | €312k | €298k | €293k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts JK - TRADING signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
2 contracts with 1 buyer · €52k
| Contracts | Value | |
|---|---|---|
| Národný ústav reumatických chorôb | 2 | €52k |
Open public tenders for JK - TRADING →
Latest contracts
Public tenders won
3 tenders won since 1 Jan 2024 from 1 public buyer in Slovakia. From EU award notices (TED) that name JK - TRADING by its registry number.
Jobs at JK - TRADING
Leadership
- Jaroslav Knap · Konateľ (Managing director)Source: business register
- Pavel Strnad · Konateľ (Managing director)Source: business register
More health & medtech companies
JR – NeuriMedica
Neurology outpatient clinic in Bytča, Slovakia, providing diagnosis and follow-up care for adult patients with nervous system disordersYoung companyProfitableJuvenalia
Pediatric outpatient clinics and a children's day hospital in Dunajská Streda, Slovakia, for children and adolescentsProfitableNew on EvolcJuvepharm
Importer and distributor of dermatocosmetic and health brands for problem skin, herpes infections and immunity, sold in Slovak pharmaciesYoung companyProfitableGrowingK&M MEDIA
Medical supplies, equipment and military products for healthcare providers and security organizationsProfitableGrowingNew on EvolcK.P. HARMONY
Clinical and transport psychology services for adolescents and adults in Prešov, SlovakiaProfitableGrowingNew on EvolcKabínka Vitality
Private wellness sessions combining salt therapy, red and infrared light, and oxygen therapy for individuals and familiesYoung companyProfitableGrowing
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.